)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Hamlet BioPharma
Hamlet BioPharma (HAMLET) investor relations material
Hamlet BioPharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Feb, 2026
Executive summary
Achieved major milestones including completion of three Phase II studies in cancer, infection, and chronic pain, and secured drug production for Phase III studies.
Positive FDA feedback supports pivotal Phase III study for Alpha1H in non-muscle invasive bladder cancer, with advanced preparations underway.
Published successful Phase II results for non-antibiotic treatment of acute cystitis, showing efficacy comparable to antibiotics.
Entered a partnering agreement with ImmunoForge for novel drug delivery technology for tuberculosis treatment.
Ongoing global commercialization and partnership efforts, with a new CEO appointed to lead the next phase.
Financial highlights
Net sales were KSEK 0 for both the quarter and first half, reflecting the pre-revenue stage.
EBITDA for the quarter was KSEK -13,026 (previous year: -11,847); for the first half, KSEK -22,651 (previous year: -19,649).
EBIT for the quarter was KSEK -15,579 (previous year: -14,481); for the first half, KSEK -27,739 (previous year: -24,917).
Net result for the quarter was KSEK -15,431 (previous year: -14,387); for the first half, KSEK -27,588 (previous year: -24,651).
Cash at period end was KSEK 16,638 (previous year: 30,416); equity/assets ratio was 83.6% (previous year: 92.8%).
Outlook and guidance
Immediate goal is to conduct Phase III studies and obtain market approval for Alpha1H in bladder cancer.
Actively exploring additional funding avenues and global partnerships for commercialization.
Strategic focus on advancing preclinical assets and expanding the clinical pipeline.
Alpha1H Phase III funding strategy?
Specific market advantage of non-antibiotic drugs?
What is the next step for Alpha1H protocol design?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hamlet BioPharma
- FDA backs pivotal trial for Alpha1H; leadership transitions and pipeline expansion underway.HAMLET
Life Science Summit 202525 Nov 2025 - Phase II successes, SEK 140M capital raised, and FDA support position Alpha1H for Phase III.HAMLETQ1 202614 Nov 2025
- Advanced phase 2 results, strong funding, and novel infection treatments drive future growth.HAMLETInvestor Update31 Oct 2025
- Strong Phase II results, robust pipeline, and new capital support advancement to Phase III trials.HAMLETQ4 202528 Aug 2025
- Novel antifungal peptides advance toward clinical trials for drug-resistant tuberculosis.HAMLETInvestor Update18 Jun 2025
- Positive Phase II results drive clinical momentum, but ongoing losses highlight funding needs.HAMLETQ1 202513 Jun 2025
- Clinical progress and strategic expansion drive Hamlet BioPharma amid rising R&D costs.HAMLETQ4 202413 Jun 2025
- Alpha1H advances to Phase III after strong Phase II results; financials reflect ongoing R&D investment.HAMLETQ3 20256 Jun 2025
- Positive Phase II data and SEK 26.8M raise position Hamlet BioPharma for next-stage growth.HAMLETQ2 20255 Jun 2025
Next Hamlet BioPharma earnings date
Q3 202622 May, 2026
Hamlet BioPharma
Next Hamlet BioPharma earnings date
Q3 202622 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Hamlet Pharma AB, a pharmaceutical company, engages in the research and development of cancer drugs. The company's lead product candidate is a patented drug that combines the active ingredient Bisantrene-Guanidinylpenicillamine in a galenic form suitable for oral administration. Its BAR treatment is administered through small pills that slowly release the active ingredient into the upper part of the gastrointestinal tract. The company is headquartered in Malmö, Sweden.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage